ILD status at diagnosis of the cases with available information on lung disease in patient chart reviews (n=73) and associations with reported occurrence of inflammatory lung disease and smoking
| ILD | ||||
|---|---|---|---|---|
| Yes, n (%) | No, n (%) | OR (95 CI) | p Value | |
| Total | 12 (16) | 61 (84) | ||
| Exposed to lung disease at study inclusion | ||||
| No | 3 (25) | 39 (64) | Reference | |
| Yes | 9* (75) | 22† (36) | 5.3 (1.3 to 21.7) | 0.02 |
| Excluding IBM cases‡ | ||||
| No | 3 (25) | 36 (66) | Reference | |
| Yes | 9* (75) | 18§ (33) | 6.0 (1.4 to 24.9) | 0.01 |
| Exposed to lung disease before index year | ||||
| No | 5 (45) | 41 (76) | ||
| Yes | 6¶ (55) | 13** (24) | 3.8 (1.0 to 14.5) | 0.05 |
| Excluding IBM cases†† | ||||
| No | 5 (45) | 41 (80) | Reference | |
| Yes | 6¶ (55) | 10‡‡ (20) | 4.9 (1.2 to 19.4) | 0.02 |
| Ever smoker | ||||
| No | 6 (50) | 35 (57) | Reference | |
| Yes | 6 (50) | 26 (43) | 1.3 (0.4 to 4.7) | 0.64 |
*Seven cases with pneumonia and two cases with tuberculosis.
†Twenty cases with pneumonia (of which one exposed also to tuberculosis) and two cases with sarcoidosis.
‡Five verified (two with pneumonia) and two suspected (both with pneumonia) IBM cases; all negative for ILD.
§Sixteen patients with pneumonia (including one case exposed also to tuberculosis) and two with sarcoidosis.
¶Four cases with pneumonia and two cases with tuberculosis.
**Eleven patients with pneumonia (including one case exposed also to tuberculosis) and two with sarcoidosis.
††Two verified (with pneumonia) and one suspected (with pneumonia) IBM cases; all negative for ILD.
‡‡Eight patients with pneumonia (including one case exposed also to tuberculosis) and two with sarcoidosis.
IBM, inclusion body myositis; ILD, Interstitial lung disease.